The total return over the past 12 months is +52.43% vs. +16.94% for the S&P 500. So far it's up +175.35% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +52.43% | (3.93%) | (39.88%) | (40.32%) | (31.97%) | N/A |
| Total Return CAGR | +52.43% | (3.93%) | (39.88%) | (40.32%) | (31.97%) | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Edesa Biotech, Inc. (EDSA)
| Year | Start price | End price | EDSA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.42 | $3.91 | +175.35% | +14.51% | +160.84% |
| 2025 | $1.68 | $1.42 | (15.48%) | +17.72% | (33.20%) |
| 2024 | $4.57 | $1.68 | (63.24%) | +24.89% | (88.13%) |
| 2023 | $15.12 | $4.57 | (69.78%) | +26.19% | (95.97%) |
| 2022 | $39.41 | $15.12 | (61.63%) | (18.17%) | (43.46%) |
| 2021 | $29.75 | $39.41 | +32.47% | +28.74% | +3.73% |
| 2020 | $28.70 | $29.75 | +3.66% | +18.37% | (14.71%) |
| 2019 | $38.22 | $28.70 | (24.91%) | +31.22% | (56.13%) |
| 2018 | $238.14 | $38.22 | (83.95%) | (4.56%) | (79.39%) |
| 2017 | $596.82 | $238.14 | (60.10%) | +21.70% | (81.80%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
